| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |